申请人:THOMPSON, III LORIN A.
公开号:US20130131051A1
公开(公告)日:2013-05-23
Compounds of formula (I), including pharmaceutically acceptable salts thereof, are set forth herein:
wherein X is selected from the group of CH
2
, O, and NR
2
;
m=0 or 1;
R
1
at each instance is selected from the group of halogen, hydroxy, amino, C
1-4
alkylamino, C
1-4
dialkylamino, haloC
1-4
alkyl, CN, C
1
-C
6
alkyl or cycloalkyl, C
1
-C
6
alkoxy, and C2-C4 alkynyl;
L is a bond, —NHCO—, —NH—, or L and Z together can be absent;
Z is a C
6
-C
10
-aryl group or a 5-10 membered heterocyclic group which can be further substituted with from 0-3 substituents selected from the group of halogen, haloC
1-4
alkoxy, 4-methoxyphenyl, hydroxy, amino, C
1-4
alkylamino, C
1-4
dialkylamino, haloC
1-4
alkyl, CN, C
1
-C
6
alkyl or cycloalkyl, C
1
-C
6
alkoxy, and C
2
-C
4
alkynyl;
R
2
is selected from the group of hydrogen, benzyl, C
1
-C
6
alkyl or cycloalkyl, C
1
-C
6
alkoxy, acetyl, and methanesulfonyl;
and R
3
, R
4
and R
5
are independently selected from hydrogen or C
1-4
alkyl.
以下列出了
化学式(I)的化合物,包括其药用可接受的盐:
其中,X选择自
CH2,O和NR2的群;m为0或1;每个R1选择自卤素,羟基,
氨基,C1-4烷基
氨基,C1-4二烷基
氨基,卤基C1-4烷基,CN,C1-C6烷基或环烷基,C1-C6烷氧基和C2-C4炔基的群;L为键,-NHCO-,-NH-或L和Z一起可以不存在;Z是C6-C10芳基或5-10成员杂环基,可以进一步用来自卤素,卤基C1-4烷氧基,4-
甲氧基苯基,羟基,
氨基,C1-4烷基
氨基,C1-4二烷基
氨基,卤基C1-4烷基,CN,C1-C6烷基或环烷基,C1-C6烷氧基和C2-C4炔基的0-3个取代基置换;R2选择自氢,苄基,C1-C6烷基或环烷基,C1-C6烷氧基,乙酰基和甲磺酰基的群;而R3,R4和R5独立选择自氢或C1-4烷基。